Introduction
Cardiovascular diseases (CVD) are the leading cause of mortality worldwide, with an estimated 17.7 million deaths per year due to CVD. This is approximately 30% of all global deaths annually and represents a 3-fold increase in mortality rates since the early 1950s. In addition, heart failure alone accounts for over 1 million hospital admissions per year in Europe and North America with costs exceeding $25 billion dollars annually in the United States alone. Say’s Dr John Strobeck, despite these alarming statistics, fewer than half of those who suffer from CVDs receive appropriate treatment because these preventative measures have not been adopted by healthcare systems due to cost concerns or lack thereof education among healthcare providers themselves
Cardiovascular diseases are the leading causes of death in the world.
Cardiovascular diseases are the leading causes of death in the world, accounting for 17.3 million deaths in 2015 alone. Cardiovascular disease (CVD) is a broad category that includes heart disease, stroke and peripheral vascular disease. In the United States, about 1.4 million people die each year from CVD – that’s one in every four deaths!
The healthcare industry must improve its practices to provide high-quality care to all patients with CVDs.
The healthcare industry must improve its practices to provide high-quality care to all patients with CVDs. Patients with CVDs often experience difficulties accessing care, especially in rural areas where there may be a lack of specialized physicians who can diagnose and treat their conditions. Additionally, some patients are unable to afford medications or other treatments that could improve their health outcomes if they had access to them. These issues underscore the need for improved access and quality of care for patients with CVDs across the United States.
There are promising new therapies that can help patients with heart failure, hypertension and diabetes.
There are promising new therapies that can help patients with heart failure, hypertension and diabetes. The healthcare industry must improve its practices to provide high-quality care to all patients with CVDs. The healthcare industry is making progress in this area.
Conclusion
Cardiovascular disease is one of the leading causes of death in the world. It is essential that we improve our practices so that all patients can receive high-quality care no matter where they live or how much money they have. There are many promising new therapies on the horizon that could help patients with heart failure, hypertension and diabetes
